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SSA / R o and SSB/ La a re so luble cellular proteins to whi ch 
antibo dies a re freguently produ ced in patients with Sjo-
g ren 's syndrome and systemic lupus erythe m atosus . In thi s 
inves tiga tio n, w e examined anti-SSA / R o and anti-SSB / La 
s taining p atte rn s o n synchro nized WiL2 cells and mixed 
ly mphocyte culture cell s using monosp ecifi c antisera. In 
addition to its presence in the nucleoplas m, the SSB/ La 
antigen was hi g hl y con centra ted in th e nucl eolus of cells 
A pro min ent findin g in pa tients with conn ecti ve tissue diseases is an alterati on in immunologic responses, including the production o f autoantibodies to a va-riety of antigens. Two such antigens are' SSA/ Ro and SSB/La, soluble cellular proteins whose exact 
location , nuclear and /or cyto plasmi c, has ye t to be clearly deter-
mined [1] . Antibodi es to these pro teins arc most commonl y fo und 
in patients with Sj ogren 's synd ro me (sicca co mplex) and sys temic 
lupus erythematosus (SLE). Additi onall y, anti-SSA/Ro antibod-
ies can be detected in patients with so-ca lled ANA-negative SLE, 
neonatal LE, subacute cutaneous LE, and mo re recentl y, com-
plement component C 2 defi ciency [2-5) . 
An tibodies to SSA/ Ro and SSB/ La coexist frequently in these 
patients [6 ]. T his situatio n is comparable to th e co-occurrence of 
antibodies to Sm and nRNP [7] and sugges ts a close relationship 
between the anti gens, perh aps due to shared RNA [8-1 0]. 
Recentl y in cell synchroniza tion studies , we found that the 
SSB/ La antigen is present in th e nucleoplas m of cells in th e res tin g 
phase; it beco mes hi g hl y concentrated in the nucleolus in the Ia tc 
G , and/or ea rl y S phase, and then return s to the nucleoplasm in 
late S, G2 , and M phases [111 . In this paper we confirm our 
prev io us wo rk on the express ion o f SSB/ La antigen and extend 
o ur data to a compari son w ith the subcellular loca tion o f SSA/ Ro 
at d ifferent phases of the cell cycle. The 2 anti gens are sho wn to 
be ex pressed at different phases o f the cell cycl e, and at different 
intracellular locatio ns during late G , to ea rl y S pl13se; however, 
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during the late G , and ea rly S phase and is thus cell cycle -
rela ted . In contrast , th e SSA/ Ro antigen w as found to b e 
inde pendent of cell cycle, sho wing a nucl ear speckled pat-
te rn in all phases. Blockin g expe riments indica ted that free 
SSB/La is respo n sible for the nucl eolar staining, whe r eas 
the combination of both SSA/ Ro and SSB/La d e te rmine s 
th e nucleoplasmic speckled staining p attern. J In vest D e/'-
matoI 87:504-509, 1986 
competition data suggest some antigeni c relatio nship between 
th em . 
MATERIALS AND METHODS 
Cell Culture WiL2 human dipl oid B-Iymphoblasto id cells w ere 
maintained in suspension culture at 37°C in minimal essential 
medium (M EM) supplem ented with 10% heat-inactivated fetal 
bo vine se rum , MEM no nessenti al amin o acids, M E M vitamins, 
sodium pyruva te, 2 mM glutamine, and antibi oti cs (G ibco, Buf-
falo , N ew Yo rk) . The cells were subcultured every 3 days at a 
concentration of2.0 x 105/ ml, except durin g th e synchronizatio n 
experiments. 
T o determine DNA synthes is and degree o f mitos is, 1. 0-ml 
aliquo ts o f cell suspensions containing 2.0 x 105 cell s/ml w ere 
pulsed wi th 10 ILC i/ ml [JH)thym.idine (N ew E ngland Nuclear) 
fo r 30 min . The cells were then washed twi ce with phos phate-
buffered sa line (PB S, 0.01 M phosphate, 0.15 M NaC I, pH 7.4) . 
C ytocentrifu ga tio n spreads o f these cells were prepared and fi xed 
in ace tone fo r 10 min at room temperature. Processing slides fo r 
autoradiography included immersin g th em in Kodak NTB-2 nu-
clea r emulsion (Eas tm an Kodak Co., Roches ter, N ew York) , 
drying at room temperature, and incubating for 7 days. Slides 
were then develo ped in Kodak develo per 19, fi xed in Kodak fixer , 
and stained with G iemsa. T he perccntages of labeled and mito tic 
cells w ere expressed as 'Iabeled index and mito ti c index. 
Synchronization of WiL2 Cells Two different methods of 
synchroniza tion were used to study the distribution of the SSA/ Ro 
and SSB/ La antigens in the various phases o f the cell cycle. In 
th e first meth od , WiL2 cells were synchronized by starvation o r 
density-dependent arres t as described previously [1 2]. After seed-
in g at a concentratio n o f 2 X 105/ ml , cell count and viability 
w ere determined every day for 7 days using the 0.05% try pan 
blue exclusion method witho ut addition o f new medium. On the 
sixth day o f culture, 60% of the cells remained viable and less 
than 1 % and 0. 1 % o f the cells were showin g DNA synthesis and 
mitosis, respectively (Fig 1). Pro tein synthesis was minimal (data 
no t shown) . Thus, 6-day-o ld cells were considered to be in Go 
phase. C ultures of th ese cells w ere gro wn in complete fresh m e-
dium at a concentration o f 2. 0 X 105/m l. T hey were harvested 
immediately and every 2 h therea fter, washed once with PBS and 
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Figure 1. WiL2 cells were grown in suspension culture at 37°C. Dail y 
cell COllnts were depicted by the growth curve (so lid circles). Incorpo ration 
of e HJth ymidine (opCI/ circles) and percentage of ce lls in D NA synthes is 
(labeling index. tri(/ I/gles) were determined by rad ioactivity cOllnting (cpm) 
and a uto radiograph y, res pec ti vel y. By the sixth day of culture, less than 
100/0 o f the ce ll s showed DN A synthes is. Also. less than '1 % o f these 6-
day- o ld ce lls demo nstrated mitoti c acti vity (no t shown). T hese were thus 
con s idered to represent the Gu or res ting phase. 
cy tocentrifu ged onto g lass microscope slides, and used fo r indirect 
imITlun o Auo rescence. Some cells were harves ted every 3 h, pulse-
lab e led with [3H]th ymidine, and processed fo r auto radiograph y 
to d e termine thymidine uptake, labeling index, mito tic index as 
described above (Fig 2). 
In the second Ill ethod, WiL2 cells were arrested at the late G1 
or ea rl y S phase of g rowth using the hydroxyurea blockade [13] . 
In this method, 2-day-old cells in the log phase o f g rowth were 
trea t ed with 4 mM hydroxyurea fo r 17 h. T he hydroxyurea was 
rem.oved by washin g and res uspending th e cell s in fresh, pre-
warmed culture mediulll . Cells were harvested at 0 h and every 
2 h therea fter, similar to the density-dependent arres t procedure. 
Mixed Lymphocyte Cultures Blood was d rawn from 2 healthy 
human subj ects who had no symptoms of connective tissue dis-
ease . T he lymphocytes from each subject w ere iso lated using the 
Iso p aque-Fico ll techniqu e o riginall y described in 1968 [1 4]. The 
blood w as diluted twi ce w ith culture med ium and the solution 
was ca refull y layered over 10 ml o f Histopaque (Sigma C hemica l 
Co ., St. Louis, Missouri) . The mixtu re was centrifu ged at 2000 
rpm for 15 min . The mononuclear cell-containing layer was clearly 
identifi ed and removed using a pipet. Lymphocytes from each 
subject w ere divided. The first g roup w as w ashed, resuspended 
in PBS, and cytocentrifuged onto g lass slides (0 h) . The remaining 
lym p hocytes were mi xed together and incubated at 37°C for 6 
days. Labeling index and [3H]thymidine uptake were also deter-
m ine d as described above. By 3-4 days of culture, some of the 
cells b egan showing DNA synthesis, and cells from the 4-day-
old culture were harvested and used fo r indirect immuno Auores-
cen ce (Fig 3). 
Se ruITI Specimens The human sera used in this study contained 
monospecifi c antibodies either to the SSA/ Ro o r SSB/ La antigen. 
Th e m Ol1os pecificity o f th ese sera was based on the production 
of a s ing le precipitin line on double immunodi ffu sion and coun-
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Figure 2. Determination of thc ce ll cyclc phascs of WiL2 by dcnsity-
depcndent arres t. IJH IThymidinc uptakc (trial/s ics) , percentage of ce lls in 
mitosis (mi totic index, solid circles), and percentage of cells in D N A syn-
thes is (l abeling indcx, OpCI/ circles). were dctermined every 3 h. 111 the fi rst 
6 h. grca ter than 90% of cells showcd 110 D N A synthesis, bu t subsequcntly 
they entered D NA synthes is, reaching a maximum bctween 15-18 h. 
Fo llow ing a rapid decline in thcsc synthetic cell s (S phase), signi fi cant 
nllmbers of mi to ti c cell s appearcd at 21-24 h. 
terimmuno lectrophores is usin g WiL2 cell extract as the antigeni c 
source. In immunodiffusion, lines of immunologic identity were 
fo rlll ed with standard reference sera, es tablishin g th e identity of 
the precipitating antibody. In addition, sera containing anti-SSA/ Ro 
antibodies gave a negative Au orescent antinuclea r antibody assay 
when mouse kidney section was used as substrate [1 5]. but a 
speckled nuclea r illllllunoAuorcscence pattern on human H Ep-2 
and WiL2 cells [1 5, 16]. T he anti-SSB/La antisera produ ced . a 
speckled nuclea r Auo resccnce pattern on both rodent tissue section 
and tissue culture cells . O ther criteria included specifi c RN As 
idcntified by imlllunoprecipitation, a specifi c peptide recogni zed 
in imlllunoblot analysis , and a negati ve radioimmunoassay or 
enzy me-linked immunoso rbent assay (ELI SA) fo r DNA or his-
tonc antibody assays [9, 17]. FOll[ sera havin g anti-SSA/Ro an-
tibody onl y were included in this stud y. Two anti-SSB/a scra 
th at fulfilled the above criteria were selected and further subj ected 
to SSAlRo ELISA to prove no contamination of anti-SSA/ Ro 
acti vity, and then used in th is stud y. 
SSA/Ro Enzyme-Linked Immunosorbent Assay SSA/ Ro 
was purified from WiL2 cell extract by amlll oniulll sul fa te pre-
cipitation, polybuffer exchanger ion exchange chromatography, 
and fo llo wed by preparative 10% acrylalllide electrophoresis as 
dcscribed by Lieu et al [1 8]. SSA/Ro was also purified by anti-
SSAlRo affinity column chromatography as described by Ya-
maga ta et al [J 91. Purified SSA/ Ro antigen was coated onto Illi-
croti tration plates at the concentration of 0.1 J.L g/w ell and used 
fo r SSA/ Ro ELI SA. For E LISA, human sera were dilu ted to 
1 :100, 1 :200, 1 :400, and 1:800 with T ris-saline buffer, pH 7.4 
containing 0.05% T ween and 1 % bovinc serUIll albulllin . T he 
diluted sera were added to Illicrotitration plates and incubated at 
37°C fo r 2 h. Following thorough washing in T ris-saline buffe r 
with 0.05% T ween, ho rseradish peroxidase (HRP)-labcled goat 
antihuman IgG (1:1 000 diluti on)(Ca ppel La borato ry, Cochran-
ville, Pennsylv:lI'lia) was added and incubated fo r ano ther 2 h. 
After w ashin g, substrate w as added and opti cal density reading 
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at 405 nm using Dynatech Micro ELISA plate reader was un-
dertaken. 
Indirect Immunofluorescence The substrates used for im-
munofluorescence were WiL2 cells and human peripheral blood 
lymphocy tes. Aliguots consisting of 0 .1 ml of cell suspension 
were cytocentrifu ged onto glass microscope slides and fi xed in 
acetone for 10 min. Sera containing anti-SSA/Ro and anti-SSB/ 
La antibodies w ere rea cted with the substrate for 30 min and then 
washed in PBS for 5 min . The conjuga te used was flu orescein 
isothiocya nate (FITC)-Iabeled goat antihuman IgG with the fol-
lowing characteristi cs: FITC, 132 p.g/ml; protein, 14 mg/ml; an-
tibody activity, 32 units/ml ; plateau endpoint, 1 :128 dilution . This 
antiserum was diluted 1:100 in PBS. The cells were incubated 
with conju gate for 30 min , then w ashed again for 5 min in PBS . 
The slides were counterstai ned with Evans blue, mounted with 
buffered glycerin e, and read using a Zeiss epifluorescent micro-
scope. Normal human serum or PBS was used as a negative 
control. 
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Figure 3. Fluorescent staining of synchronized 
WiL2 cells by the density-dependent arrest/_ 
starvation method. Cells stained with anti-SSB/La 
are shown in (A) and (C), and those stained with 
anti-SSA/Ro in (B) and (D) . A mId B, Cells in Go 
phase: A = Go cells stained with SSB/La; B '=' 
Go cells stained with SSA/Ro. In both instances 
one can see a nuclear speckled pattern . C and D: 
Cells in late G, and early S phase. SSB/La staining 
(C) reveals a prominent nucleolar pattern in ad-
dition to the nucleoplasmic speckles, but SSA/Ro 
staining (D) yields only the nuclear speckling. 
Purification of IgG and Labeling with FITC IgG was pu-
rified from monospecific anti-SSA/Ro and anti-SSB/La human 
antisera by ammonium sulfate salt precipitation and DE-52 ion 
exchange chromatography . The purified IgG was then coupled 
with FITC as described above [20] . Fluorescein isothiocyanate-
conjugated specific IgG was then used for the competition ex-
periments described in the following section. 
Competition Experiments WiL2 cells were synchronized and 
harves ted 8 h after initiation of the starvation synchronization. 
The cells were incubated for 30 min at room temperature with 
1:5 dilution of anti-SSA/Ro IgG. This IgG was isolated from a 
monospecific anti-SSA/Ro antiserum, yielding a precipitin anti-
SSA/Ro titer of 1 :16. Following incubation, cells were washed 
in PBS and incubated with FITC-Iabeled anti-SSB/La IgG for 30 
min . The cells were washed, mounted with glycerin, and ex-
amined using a fluorescent microscope. A second set was prepared 
usin g synchronized cells incubated with anti-SSB/La IgG fol-
lowed by FITC-Iabeled anti-SSA/Ro IgG. 
Table I. C haracteristics of Anti-SSA/Ro and Anti-SSB/La Reference Sera 
SSAlRo 1<1 
2 
3 
4 
SSB/La 1 
2 
IIWiL2 cell smears. 
Mouse 
Negative 
Negative 
Negative 
Negative 
Speckled 
Speckled 
Precipitin 
WiL2" Line 
Speckled Single 
Speckled Single 
Speckled Single · 
Speckled Single 
Speckled Single 
Speckled Single 
Immunoblot RNA 
Analysis Profile 
60K 2 RNAs 
60K 2 RNAs 
60K 2 RNAs 
60K 2 RNAs 
43K 6 RNAs 
43K 6 RNAs 
' ELI SA OD reading of serllm di lution I: 100 using affi nity-purified SS A / Ro ELISA plates. Normal human se rum control < 0.179. 
SSA ELISA 
Ab B' 
0.475 0.615 
0.546 0.714 
0.593 0.610 
0.415 0.496 
0.088 0.139 
0.105 0.156 
' ELISA OD reading of se rum di lution I: 100 using polybuffer exchanger ion exchange chromatography and acry lamidc gel electrophoresis purified SSA/Ro ELISA plates. 
Normal human serum control < 0. 200. 
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RESULTS 
Monospecificity of the Reference Sera The characteristics of 
the sera used in this study are shown in Table I. All of the 4 anti-
SSA/Ro sera were ANA-nega tive on mouse kidney sections, but 
gave a speckled nuclear staining pattern on WiL2 cell substrate 
[15 , 16], and had only 1 precipitin line in double immunodiffusion 
and counterimmunoelectrophoresis [9,17]. As shown before, they 
precipitated 2 small cellular RNAs in immunoprecipitation using 
32p_Iabeled WiL2 cell extract as the source of antigen. Moreover, 
they recognized on ly a 60,OOO-dalton peptide in immunoblot anal-
ysis [17]. Based on these criteria. it was quite certain that those 
anti-SSA/Ro sera were monospecific based on current available 
techniques. All these sera reacted in SSA/Ro ELISA . The 2 anti-
SSE /La reference sera gave also onl y 1 precipitin line in cOlln-
terimmunoelectrophoresis and double immunodiffusion, and were 
ANA-positive of speckled pattern , in mouse kidney sections and 
WiL2 cell smea rs. They recognized only a peptide of 43,000 dal-
tons in immunoblot analysis [17]. Moreover, they precipitated 6 
RNAs, 2 of which migra ted to the same points as the RNAs 
precipitated by anti-SSA/ Ro sera [17] . However, these 2 sera did 
not react in SSA/Ro ELISA . This indicated that these 2 anti-
SSE/La sera did not contain detectable anti-SSA / Ro antibody 
activity and were assumed to be very monospecific and used in 
the present study . 
Growth Curves Cell counts and viability of the WiL2 cell 
cultures were determined daily for 7 days and these results are 
shown in Fig 1. D uring the first 24 h, the cells were considered 
to b e in the lag phase, w hile between day 1 and day 4, they 
entered the log or exponential growth phase. The cell count pla-
teau ed at days 4-5 and then began to decline (death phase). Vi-
ability (not shown) was maximal (90-95%) during cell growth , 
but started to decline on the fifth day. 
Synchronization by Density-Dependent Arrest T he results 
depicting [3H]thymidine uptake, labeling index , and mitotic index 
are shown in Fig 2. In the first 6- 9 h, most of the cells (90% ) 
were in a phase with no DNA synthesis. At 9 h of culture, cells 
entered DNA synthesis, which reached a peak at about 18 h. 
Significant numbers of mito tic cells appea red at 24 h of culture. 
Fronl these res ults, it was concluded that the first 9 h after release 
from density-dependent arrest represented the G 1 phase. S phase 
cells included those showing D NA synthesis (9-21 h), and Gz 
and M phases w ere present at 21-24 h. 
Inllnunofluorescent Staining U sing monospecific serum for 
anti-SSE/La antibodies, immunofluorescent staining revealed a 
nuclea r speckled pattern in the Go and G 1 phases as seen in 
Fig 3A . In late G 1 and early S phase (Fig 3C), there was strong 
nucleolar staining in greater than 90% of the cells in addition to 
the nucleoplasmic staining. During S phase, the speckled pattern 
remained , but the nucleolar staining had almost disappeared (not 
shown). T he mitotic phase cells showed speckled staining sur-
rounding chromosomes (not shown). The peak time for the nu-
cleolar prominence was at 8 h, corresponding to late G 1 and early 
S phase. 
Observations using an tibody to SSA/Ro are also shown in 
Fig 3B,D. All gave speckled nucleoplas mic staining, but there 
was no evidence of nucleolar staining similar to that seen with 
anti-SSB/La antiserum. [n addition, when both anti-SSA/Ro and 
anti-SSE/La antisera were serially diluted, only reduced staining 
intensity was noted without a change in staining pattern. 
T hese results were confirmed by synchronization of the WiL2 
cells with hydroxyurea block. Following release from the hy-
droxuyrea trea tment, cells immediately entered the late G 1 and/or 
early S phase of the cycle. When these cells were stained with 
anti-SSB/La antiserum, they displayed a prominent nucleolar pat-
tern with nuclear speckling. Staining w ith several monospecific 
sera for anti-SSA/Ro gave similar results, i. e., fine nuclear 
speckles withf)ut nucleolar staining. 
The mixed lymphocyte culture (MLC) was used as an addi-
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Figure 4. The mixed lymphocyte culture. At day 0 lymphocytes fro m 
2 subjects were mixed and incubated. Increases in DNA synthesis (labeling 
index, opell circles) and pH]thymidine uptake (so lid circles) began at 3-4 
days . The 4-day-old cells were considered to represent the beginning of 
the S phase. 
tional method to confirm the above observations. When lym-
phocytes from 2 geneticall y di fferent individuals were mi xed and 
cultured together, they underwent blast- transformation and pro-
liferation . D NA synthesis began at 4 days of culture, shown in 
Fig 4. At 0 h prior to mixing the lymphocytes, immunofluores-
cence using PES as a control revea led background and fine cy-
toplasmic staining. Examination of the MLC at 4 days coincided 
with the beginning of DNA synthesis or ea rl y S phase of the cell 
cycle. T he control showed only background staining as on the 0 
h sm ear and the SSB/La antiserum revealed a nucleolar as well 
as nuclear speckled pattern (Fig SA) . Anti-SSA / Ro sera eli cited 
nucleoplasmic staining wi th some cytoplas mic staining, but fai led 
to stain the nucleolus (Fig 5B) . 
Competition Experiments Synchronized cells of late G 1 and 
ea rl y S phase were incubated w ith anti-SSA/Ro IgG followed by 
F1TC-labeled anti-SSB/LA IgG, o r anti-SSB/La IgG followed by 
FITC-Iabeled anti-SSA/Ro IgG. T here was nucleoplas mic and 
nucleo lar speckled staining 111 cells trea ted w ith anti-SSA/Ro fo l-
lowed by FITC-Iabeled anti-SSE/La IgG. T his corresponded to 
the origina l staining given by anti-SSE/La antisera in cells at late 
G 1 and/or S phase. However, there was no staining at all when 
the synchronized cells were stained first with anti-SSB/La fol-
lowed by an FITC-Iabeled anti-SSAlRo [gG. 
DISCUSSION 
T he present investigation demonstrates that SSA/Ro and SSE/La 
cellular antigens are predominantly nuclea r in location and show 
speckled or particulate staining patterns by fluorescence micros-
copy. These results confirm the reports of o'thers r1 ,15-17,21,22]. 
In addition , we have illustrated how the SSA/Ro and SSB/La 
antigens are different at the cellular level. T here are more SSB/ La 
than SSA/Ro nuclear speckles microscopicall y, as expected from 
the relative cellular content of these antigens as described earlier 
by Lerner et al [23]. They estimated that each cell contains 106 
copies of SSE/La but only 105 copies of SSA/ Ro. We have also 
confirmed that the SSB/La molecule is a dynamic intracellular 
component, and have extended these observations in cells 
undergoing blas toform transformation during mixed lymphocyte 
reactions. SSB/La anti gen is cell cycle-dependent, manifesting 
itself as a nuclear antigen with a nucleolar localiza tion in late G 1 
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Figure 5. Stain ing patterns of cel ls in mi xed lymphoCJjte culture. These 
photographs represent lymphocytes at 4 days of culture or the beginnin g 
of DNA synthesis. A, Promincnt nucleolus and fine Iluclea r speckled 
pattern produced by anti-SSB/La antiserum . B, Nucleoplasmic speckled 
staining with SSA/Ro. 
and earl y S phases (Figs 3C, SA) [11], while SSAlRo antigen is 
not cell cycle-dependent. This difference docs no t contradi ct the 
idea of a m o lecular relatio nship between SSA/Ro and SSB/La 
antigens [9,10]. It has been suggested that there are 2 distinct 
forms of SSB/La particles: free SSB/La and a ribonucleoprotein 
particle carry in g SSB/La and SSA/Ro anti genic ac tivities [10] . 
Both forms contribute to the nuclear speckled stainin g pattern in 
cells at Go, ea rl y G I , and late S phases, while o nly free SSB/La 
is respo nsible for the nucleolar s tainin g pattern in cells at late G I 
and/or ea rl y S phase. T his hypo thesis is supported by o ur com-
petition experiments, in which SS A/Ro antiserum did no t block 
the nucleolar staining by ant i-SSB/La antiserum in cells at late G I 
and/or ea rl y S phase. O n thc other hand , anti-SSB/La antiserum 
could effectively abolish the subsequent nuclear sta inin g by anti-
SS A/Ro antiserum . O ne possibl e explanation for these findin gs 
is contaminatio n of anti-SSB/ La activity by trace amounts of anti-
SSA/Ro an tibody. T his is unlikely because th e serum used was 
screened by strict criteria includin g a sing le peptide o f 43K rec-
ogni zed in immulloblot analys is, a sin gle precipitin lin e in CO UIl-
terimmunoelect ropho resis, the specifi c SSB/ La associated RNA 
profi le in immull oprecipitatio ll 1.9, 17J, and the negative SSA/Ro 
ELISA . Future studies usi ng monoclonal antibod ies to SSB/La 
and SSA/Ro anti gens must be performed to clarify this po int. 
T he distri bution of SSA/R o antigen in cell s is an interes ting 
question. LeFeber et al reported the detecti o n of SSA / Ro in cy-
toplasm as well as nu cleus of cultured human keratinocytes [241. 
The presence of SSA/Ro in cytoplas m was described initially by 
C lark and his associates in 1969 [25). At th at time, SSA/Ro was 
found in extract of cytoplas mi c fraction of calf thymus and hum an 
sp leen. U sin g m o nospecific hum an anti-SSA/Ro sera and purified 
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anti-SSA/Ro antibody from immunodiffusion precipitin lines, 
H armon and her associates [16] showed the intranuclea r localiza-
tion of SSA/Ro and, furthermore , they detected the presence of 
SSA/Ro in cytoplasm and nucleus, and even on ly in cy toplasm 
of cells fi xed with m eth anol of varying duration. This suggests 
that SSA/Ro is primari ly nucl ea r in loca tion and the solubility of 
SSA/Ro ant igen mig ht contribute to its cy topla smic location un-
der certain condition s. Additio nally , m ost of nuclear proteins a re 
synthesized in cytoplasm and transported to nucleus rapidl y. These 
2 fac ts might expl ain the different localization of SSA/Ro antigen 
detected by different inves ti gato rs. The m ost striking observa-
tio n , however, is the cell m embrane loca lizatio n of SSA/Ro in 
some UVB-irradiated human keratinocytes described by Le Feb er 
et al [24]. They described th e dyn amic nature ofSSA/Ro antigen , 
present on cell m embrane of viable, UVB- irradiated cultured 
human keratinocytes as well as in the cy toplasm and nucleus of 
UVB-irradiated permeabilized cultured human keratin ocy tes. If 
this is indeed a true phenom enon, it mi ght explain the photo-
sensitivity seen in patients with subacute cutaneous LE who have 
a hi g her frequ ency of pos itive anti-SSA/Ro antibody. This n eed s 
to be confirm ed furth er by monoclonal antibodies . 
Excel/wt secreta rill I slIpport by Sybil/II J-/ag(l(1 allli th e ellcollragelllellt by Dr. 
Wil/ia lll Eaglsteill , Chairlllan oj Departlllellt oj Dcnllatology, are Ilighly ap. 
preciated. The allthors are illliebted to tile scicllt(fic advice oj Dr. Byroll Bal/Oll . 
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